Drug intelligence / Profile preview

Myrialen

Development stage
Preclinical
Lead developer
Fidia Farmaceutici
Modality
Device-based Delivery → Drug Delivery Systems, Small Molecules
Administration
Ophthalmic
01

Overview

Myrialen is a branded sterile ophthalmic gel medical device containing 5% dexpanthenol, used to hydrate, lubricate, and protect the corneal and conjunctival epithelium in patients with dry eye, ocular irritation, burning, or foreign body sensation due to environmental or other noninfectious causes.[1][3][4][7] Dexpanthenol (provitamin B5) is converted in ocular tissues to pantothenic acid, a component of coenzyme A involved in epithelial metabolism and repair, supporting corneal surface healing and maintaining tear film stability.[1][3][4] The gel vehicle (with carbomer and excipients) prolongs residence time on the ocular surface, providing sustained symptom relief, and Myrialen has been evaluated in a randomized clinical investigation versus another 5% dexpanthenol gel (Recugel) in patients with moderate to severe dry eye syndrome.[3][5][13][14]

Brand names
Myrialen
Other names
Myrialen gelMyrialen Eye GelMyrialen Gel OculareMyrialen Ocular Gel

Beyond the preview

Go deeper on Myrialen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Myrialen.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call